SCHOFIELD, Wis.--(eMediaWorld)--PuraMed BioScience, Inc.(OTCBB:PMBS), a pharmaceutical company engaged in the development and marketing of a line of revolutionary, new, non-prescription medicines targeting major consumer health needs including the treatment of headaches, insomnia and general pain announced today their attendance at the NACDS Marketplace Conference in San Diego, CA on June 27, 2008 thru June 29, 2008.

The NACDS (National Association of Chain Drug Stores) Marketplace Conference is the largest and most powerful convergence of drug, food, mass merchandiser, club and value retailing in the United States, if not the world.

The epicenter for health and beauty aids (HBA) and general merchandise (GM) buying and selling, Marketplace represents more than 90 percent of the industry. Bringing together more than 250 retail companies representing 145,000 stores with 700 manufacturing companies across 11 major categories, it represents over $500 billion in annual buying power. In a phrase, Marketplace is the lifeblood of the industry.

Russell Mitchell, CEO of PuraMed BioScience who participated in the conference stated, “Having participated in NACDS Marketplace every year since 1995, I recognize the importance of this event as it relates to the launch of our products into the United States drug, food and mass retail segments. It provides us with the opportunity to update our field sales force on our activities, get a current snapshot of the state of the industry and maintain and grow our relationships within the U.S. retail community.”

About PuraMed BioScience, Inc.

PuraMed was established to capture two unique opportunities. The first is to build a substantial and profitable business, rapidly, beginning with three products developed by its founders: PuraMed Migraine™ (for acute relief of migraine headaches), PuraMed Tension Headache™ (for acute relief of tension headaches) and PuraMed Sleep™ (for insomnia). Each of these is effective and addresses a very large OTC consumer market, collectively well over $2 billion in the U.S. Each product will be unique in its class. Sales and marketing are the primary requirements for success. The Company does not require extensive personnel or infrastructure, relying instead on contractor, consultants, and third party manufacturers.

The second, longer term, opportunity is to establish a leadership position in the highly fragmented OTC natural and alternative health remedy market by introducing a “new kind of product line.” Our product line will consist of ‘alternative’ remedies for common ailments, marketed to the masses. Most consumers want products that are, first of all, effective and safe. By applying hard science to ‘natural’ products, management believes it is possible to build a line wherein each product delivers better performance with fewer side effects than its chemical counterparts. With effective marketing, these products will be embraced by the majority, many of whom prefer ‘natural’ alternatives, provided there is no need to sacrifice performance or convenience.

This news release contains forward-looking statements regarding PMBS and its future business plans, which statements involve known and unknown risks and uncertainties. Such risks and uncertainties may cause actual results and future achievements of PMBS to be materially different than those implied by these forward-looking statements. PMBS has and undertakes no obligation to provide public updates and revisions to these forward-looking statements to reflect any changes in its expectations of future events.

Major Wire Distributions  Starting at only $45 and Complete OTCBB Distribution only $249